Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Operating Margin (2021 - 2025)

Historic Operating Margin for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 5.9%.

  • Oncology Institute's Operating Margin rose 79700.0% to 5.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.92%, marking a year-over-year increase of 78400.0%. This contributed to the annual value of 15.28% for FY2024, which is 84700.0% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Operating Margin is 5.9%, which was up 79700.0% from 9.36% recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Operating Margin ranged from a high of 2.24% in Q2 2021 and a low of 78.07% during Q4 2021
  • For the 5-year period, Oncology Institute's Operating Margin averaged around 21.07%, with its median value being 16.97% (2023).
  • Over the last 5 years, Oncology Institute's Operating Margin had its largest YoY gain of 429500bps in 2022, and its largest YoY loss of -298800bps in 2022.
  • Quarter analysis of 5 years shows Oncology Institute's Operating Margin stood at 78.07% in 2021, then surged by 55bps to 35.11% in 2022, then soared by 49bps to 17.82% in 2023, then skyrocketed by 33bps to 11.9% in 2024, then skyrocketed by 50bps to 5.9% in 2025.
  • Its last three reported values are 5.9% in Q3 2025, 9.36% for Q2 2025, and 9.49% during Q1 2025.